Employees: 21 (2023.0)Legal category: SCA (commandite par actions)Size: PMECreation date: 2011-05-07 (15 years)Status: ActiveBusiness sector: Commerce de gros (commerce interentreprises) de produits pharmaceutiquesLocation: BOULOGNE-BILLANCOURT (92100), Hauts-de-Seine
LEADER SANTE GROUPE : revenue, balance sheet and financial ratios
LEADER SANTE GROUPE is a French company
founded 15 years ago,
specialized in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques.
Based in BOULOGNE-BILLANCOURT (92100),
this company of category PME
shows in 2022 a revenue of 17.8 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - LEADER SANTE GROUPE (SIREN 532353075)
Indicator
2022
2021
2020
2019
2018
2017
2016
Revenue
17 809 437 €
15 092 336 €
14 011 654 €
9 888 671 €
N/C
N/C
N/C
Net income
8 200 413 €
6 333 434 €
5 175 454 €
3 035 925 €
1 987 379 €
912 420 €
1 228 097 €
EBITDA
11 122 197 €
8 946 762 €
7 773 319 €
5 085 822 €
N/C
N/C
N/C
Net margin
46.0%
42.0%
36.9%
30.7%
N/C
N/C
N/C
Revenue and income statement
In 2022, LEADER SANTE GROUPE achieves revenue of 17.8 M€. Over the period 2019-2022, the company shows strong growth with a CAGR (compound annual growth rate) of +21.7%. Vs 2021, growth of +18% (15.1 M€ -> 17.8 M€). After deducting consumption (688 k€), gross margin stands at 17.1 M€, i.e. a rate of 96%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 11.1 M€, representing 62.5% of revenue. Positive scissor effect: EBITDA margin improves by +3.2 pts, sign of improved operational efficiency. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 8.2 M€, i.e. 46.0% of revenue. This profit can be retained or distributed to shareholders.
Revenue (2022)
?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production
17 809 437 €
Gross margin (2022)
?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed
17 121 487 €
EBITDA (2022)
?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity
11 122 197 €
EBIT (2022)
?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals
8 609 789 €
Net income (2022)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
8 200 413 €
EBITDA margin (2022)
?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability 5-10% : Average < 5% : Low
62.4%
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 16%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 71%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.5 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 47.4% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
Debt ratio (2022)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
16.497%
Financial autonomy (2022)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
71.072%
Cash flow / Revenue (2022)
?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates
47.432%
Repayment capacity (2022)
?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent 3-5 years : Fair > 5 years : Warning
0.462
Asset age ratio (2022)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
Debt ratio
10.75
183.611
102.296
63.036
24.602
10.678
16.497
Financial autonomy
62.53
30.363
42.293
50.547
65.124
77.379
71.072
Repayment capacity
None
None
None
1.572
0.641
0.333
0.462
Cash flow / Revenue
None%
None%
None%
35.837%
38.455%
43.369%
47.432%
Sector positioning
Debt ratio
16.52022
2020
2021
2022
Q1: 0.0
Med: 6.23
Q3: 53.97
Average
In 2022, the debt ratio of LEADER SANTE GROUPE (16.50) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
71.07%2022
2020
2021
2022
Q1: 15.33%
Med: 37.18%
Q3: 59.34%
Excellent
In 2022, the financial autonomy of LEADER SANTE GROUPE (71.1%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Repayment capacity
0.46 years2022
2020
2021
2022
Q1: 0.0 years
Med: 0.01 years
Q3: 1.6 years
Average
In 2022, the repayment capacity of LEADER SANTE GROUPE (0.46) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 402.77. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 0.2x. Danger: operating income does not cover interest charges, unsustainable situation.
Liquidity ratio (2022)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
402.774
Interest coverage (2022)
?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable 1.5-3 : Acceptable < 1.5 : Risk
0.197
Liquidity indicators evolution LEADER SANTE GROUPE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
Liquidity ratio
218.089
303.525
307.75
273.399
289.019
423.878
402.774
Interest coverage
None
None
None
1.626
0.573
0.371
0.197
Sector positioning
Liquidity ratio
402.772022
2020
2021
2022
Q1: 136.77
Med: 203.41
Q3: 332.18
Excellent+9 pts over 3 years
In 2022, the liquidity ratio of LEADER SANTE GROUPE (402.77) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
0.2x2022
2020
2021
2022
Q1: 0.0x
Med: 0.34x
Q3: 4.26x
Average-13 pts over 3 years
In 2022, the interest coverage of LEADER SANTE GROUPE (0.2x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 187 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 148 days. The gap of 39 days means the company finances its customers for over a month before being paid relative to supplier payments. This weighs on cash flow. Inventory turnover is 3 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. Overall, WCR represents 299 days of revenue, i.e. 14.8 M€ to permanently finance.
Operating WCR (2022)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
14 801 957 €
Customer credit (2022)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
187 j
Supplier credit (2022)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
148 j
Inventory turnover (2022)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
3 j
WCR in days of revenue (2022)
?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management
299 j
WCR and payment terms evolution LEADER SANTE GROUPE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
Operating WCR
0 €
0 €
0 €
5 563 564 €
6 486 275 €
10 895 308 €
14 801 957 €
Inventory turnover (days)
0
0
0
9
4
3
3
Customer payment term (days)
0
1041
0
182
176
198
187
Supplier payment term (days)
0
466
0
109
76
97
148
Positioning of LEADER SANTE GROUPE in its sector
Comparison with sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques
Valuation estimate
Based on 124 transactions of similar company sales
(all years),
the value of LEADER SANTE GROUPE is estimated at
6 399 614 €
(range 2 980 325€ - 22 613 935€).
With an EBITDA of 11 122 197€, the sector multiple of 0.7x is applied.
The price/revenue ratio is 0.21x
(conservative valuation).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2022
124 transactions
2980k€6399k€22613k€
6 399 614 €Range: 2 980 325€ - 22 613 935€
NAF 5 all-time
Valuation detail by method
Ajustez les pondérations selon votre analyse
EBITDA Multiple50%
11 122 197 €×0.7x
Estimation7 828 749 €
3 700 929€ - 28 493 791€
Revenue Multiple30%
17 809 437 €×0.21x
Estimation3 792 954 €
2 056 829€ - 11 488 921€
Net Income Multiple20%
8 200 413 €×0.8x
Estimation6 736 768 €
2 564 062€ - 24 601 821€
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 124 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de gros (commerce interentreprises) de produits pharmaceutiques)
Compare LEADER SANTE GROUPE with other companies in the same sector:
Frequently asked questions about LEADER SANTE GROUPE
What is the revenue of LEADER SANTE GROUPE ?
The revenue of LEADER SANTE GROUPE in 2022 is 17.8 M€.
Is LEADER SANTE GROUPE profitable?
Yes, LEADER SANTE GROUPE generated a net profit of 8.2 M€ in 2022.
Where is the headquarters of LEADER SANTE GROUPE ?
The headquarters of LEADER SANTE GROUPE is located in BOULOGNE-BILLANCOURT (92100), in the department Hauts-de-Seine.
Where to find the tax return of LEADER SANTE GROUPE ?
The tax return of LEADER SANTE GROUPE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does LEADER SANTE GROUPE operate?
LEADER SANTE GROUPE operates in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques (NAF code 46.46Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart